From: bit?!) Sent: 29 May 2019 10:20:40 +0000 lib?H6) Deborah L. CEKBJ Wilson, Breanne L. Barry, ?(9)132 I 0. Subject: Opportunity: J80 Commissioned Film, Ward 50 Please use Skype for presentation and VANTS for audio. Thanks Join Skype Meeting Trouble Joining? Try 5%:er Web A99 From: Scher, Deborah L. Sent: Tuesday, May 21, 2019 10:26 AM Toli'l'll?l Imam Cc: Wilson, Breanna L. lbw} . ya.goy> Subject: RE: Opportunity: J80 Commissioned Film, Ward SB Good Morning? By copy of this email, I am introducing you to?ur fabulous Chief Nursing Officer at the VA. -reyiewed the film trailer and is interested to discuss how we might use this film to celebrate the dedication of nurses at the VA, the impact they have on Veterans healthcare outcomes and the profession in general. Might you be able to help us organize a call with (hil?i to discuss possible next steps? Adding Bre from our office and- anlfrom office to help with scheduling. Thank you very much for making this opportunity available to us! With much appreciation, lbil?l Executive Advisor to the Secretary Secretary?s Center for Strategic Partnerships US Department of Veterans Affairs Follow us on Twitter bits.ini.coms Sent: Tuesday, May 14, 2019 4:56 PM byagow Subject: Opportunity: J80 Commissioned Film, Ward SB (19-09764-F) - 000001 I wanted to provide you some background on the Nursing! opportunity I briefly spoke about this morning. Below is a nice synopsis of what this is all about. What struck my cord, was the focus on HIV and Nursing innovation since we had just heard this with Dr. Clancy and Dr. Stoffels during their discussion. Let me know if you think the END or any other leader that would be interested in learning more about this opportunity. I would be glad to bring?on the phone to walk through the details and see ifthe VA would be interested. I will take your lead on this one. Ilbliei bitsinicom ."ll . .l'l I Con?dentiality Notice: This e-mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby noti?ed that any disclosure, copying. distribution. or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error. please reply to the sender, so that Johnson Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you. From?[mus Sent: Tues-ay, May 14, 2019 4:40 PM Totem liscrsUSI?Lu_> Subject: RE: Time Sensitive Opportunity: Commissioned Film, Ward EB Background: In 2016. 1&1. a long-time advocate for nurses, commissioned original ?lm content (directed by Dan Krauss twice Oscar Nominated} to tell the story of Ward SE. a designated ward for AIDS patients at San Francisco General. the ?rst in the country designed speci?cally to care for AIDS patients in the 19805. The story emphasizes the incredible role that nurses played in designing the Ward and caring for the patients at a time with the country was in crisis and in panic about the risk of infection. The work of these nurses changed the face of how patients with AIDS were cared for. and is a largely unknown story. In this powei?il piece of original content the story of SB is told through ?rst-person testimony of the nurses and other hospital staff who volunteered to work on the ward, as well as the patients and their loved ones, resulting in a bittersweet and moving monument to a moment in San Francisco history and a celebration of quiet heroes worthy of remembrance and renewed recognition. You can see a trailer here: (19-09764-F) - 000002 The Opportunity: II Verizon will screen the film at Festivals, in 500 theatres nation-wide starting in June, and via streaming this fall. I- 1&1 has the opportunitv to amplify and screen the film for our key partners at private events, at medical conferences, etc. II Would the VA be interested in attending private screenings? [1303!? . I role Equity 8: Partnerships Johnsam 3: .l?l'll?lsul?l Servinea. in: 411?) George Street New answiek. NJ ll it (19-09764-F) - 000003 From: Scher, Deborah L. Sent: 5 Jun 2019 19:01:21 +0000 To: Scher, Deborah Subject: Call wi_ Attachments: RE: Introduction from [?lm (19-09764-F) - 000004 From: Sent: 5 Jun 2019 18:26:35 +0000 To: Wilson, Breanna L. Subject: RE: Introduction from Bre, 11-11:30 would work! was: From: Wilson, Breanna L. Sent: Wednesday, June 05, 2019 2:21 PM l@its.jnj.com> Subject: RE: Fe: Introduction fromllbil?j Good Afternoonw lam so sorry I am delayed in my response. lfyou still have time open in your morning Deborah is freed from 9:30 until 11:30. I would be happy to set up a 30 minute call if you also have some free time in that window. Thanks, Bre Wilson Portfolio Manager Secretary?s Center for Strategic Partnerships Office of the Secretary U.S. Department of Veterans Affairs 810 Vermont Ave, NW Washington, DC 20420 Office: (202] 451-0166 Mobile: {202)412-4487 Follow us on Twitter Or on the web: From:rl??) Sent: urs ay, ay 30, 2019 3:40 PM To: Wilson, Breanna L. Cc: Wilson, Breanna L. Subject: RE: Re: Introduction from El Apologie-- have a conflict at that time but would welcome an opportunity to speak. Eire can help us find some time. Looking forward to our conversation, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary?s Center for Strategic Partnerships U.S. Department of Veterans Affairs - its.'n'.com} Date: ues-ay, May 21, 2019, 1:14 AM To: Scher, Deborah L. Subject: Re: Introduction from [m Deborah, Nice to meet you, and movinglm to with gratitude. lam in San Francisco this week, and could do a call on Wednesday around noon your time. Please let me know if that is convenient. Look forward to speaking, Sent from my iPhone (19-09764-F) - 000006 On May 20, 2019, at 12:40 PM, Scher, Deborah L. wrote: Dea- Thank you for going out of your way to make this introduction. I am most appreciative. Dearm It is a easure to meet you by email. I watched your Tedtalk and was spellbound by your courage, your determination and your compassion. When it fits with your schedule, I would welcome an opportunity to speak. Warm regards, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary's Center for Strategic Partnerships US Department of Veterans Affairs Follow us on Twitter Framl?l??} Sent: Thursday, May 16, 2019 2:38 PM To: Scher, Deborah L. l@its.ini.com> Subject: Introduction fromFb?W) Deborah, It has been a very busy week for us both and I wanted to be sure you are introduced t_ who is our Mental Health Ambassadorfor our Neuroscience division. h-as had a very diverse background and thought he would be a great person for you to speak with as you look to bring in a Suicide Prevention Strategic Director. I believe you are both already connected via Linkedin. I have copied -aboye so you can work with your schedules to connect at a good time. It is my pleasure to bring you two together. Best Regards, larva) ; _@va-sov> Subject: FW: Re: Following up - Virtual Clinical Trials Good mornin-nd [91(5) Looking to for availabilities for to schedule a call this week or early next week with Johnson and Johnson, see text below. As of right now these are Debora h's availabilities, I can find what overlaps for Dr- and hll?} schedules. If you wouldn?t mind just sending availabilities for the listed dates. Tuesday: U23: 12:30, 2:30 Wednesday U24: 9, 3 Thursday 7/25: 9:30, 10, 2, 4 Friday 1/26: 1:30, 2 Monday W29: open 9-12, 2?5 Tuesday U30: 9, 9:30, 12:30, 1, open 3?5 Wednesday 7/31: 9, 9:30, 4 Thank you, Bre Wilson Portfolio Manager Secretary?s Center for Strategic Partnerships Office of the Secretary U.S. Department of Veterans Affairs 810 Vermont Ave, NW Washington, DC 20420 Office: (202) 461-0166 Mobile: {202)412-448? Follow us on Twitter Or on the web: From:_ Sent: Monday, July 22, 2019 7:24 AM To: Scher, Deborah L. (19-09764-F) - 000010 Cc: Wilson, Breanne L. Subject: Re: Following up - Virtual Clinical Trials Hi Deborah. Thanks for the follow up! Bre. can you provide 5 datesltimes that work for the calendars of those involved? I think it will easier to find a 30min slot on a shorter time frame for multiple people. Open to feedback on this. That will give me something to circulate our team. Have a nice week! illt?l Get Outlook for Android From: Soher, Deborah L. Sent: Monday, July 22, 6:45 AM Sub'ect: RE: RE: Following up - Virtual Clinical Trials To:? [some] Cc: "Ison, 'reanna L. Good morning- I hope you had a nice weekend and managed to stay cool. I had a brief conversation with -n Friday. He is eager to move forward on this. A helpful next step would be to arrange a call with a small group of people to share thoughts on how we might best to do a ?rst virtual trial together in lung cancer and then arrange a follow up working session. Bre can coordinate the VA participants which would and me. Who should she work with on your team? Would be great to get this scheduled for this week or the early part of next week Thank you very much for your partnership on this, Best, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretaryis Center for Strategic Partnerships US. Department of Veterans Affairs Date: Wednesday. Jul 2019, 9:19 AM To: Scher, Deborah L. Subject: RE: Following up Virtual Clinical Trials (19-09764-F) - 000011 Hi Deborah, Correct Lorie and I met yesterday to move the process forward. My ask about some additional information regarding virtual clinical trials was to inquire as to whether there was something approved to circulate for this ask- 0k if there?s nothing available, just thought to ask. We arrived on a list of stakeholders that we'd include and will look to you for dates in August once Dr-gets back up and running after vacation! Thanks. ?Pharmn. ms Scientific Director, National Accounts Real World Value Evidence. Field Janssen Scienti?c Affairs LLC 1125 Trenton-Harbourton Rd. Titusville NJ 03560 Mobil! Desk hit?} (bite) its.'n'.com Confidentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient. you are hereby noti?ed that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson 3; Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you.P Please consider the environment before printing this email From: Scher, Deborah L. Sent: Wednesday, July 2019 7:53 AM Tozlbif?i Subject: RE: Following up - Virtual Clinical Trials Good morning- Thank you very much for the call you organized and for your follow up. As a next step, my understanding was that tblt?) was going to organize your lung cancer subject matter experts and brief them on th po ential collaboration. In parallel, I committed to reach out to our oncology leadership to discuss this specific Opportunity. We would then arrange a call with everyone to discuss overall parameters of what we might do together. Dr. ?has been on vacation but he and are scheduled to speak on Friday. Let me come back to you after he and have that conversation. With appreciation for your partnership, (19-09764-F) - 000012 Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary's Center for Strategic Partnerships US. Department of Veterans Affairs tins? Date: Yuonay, ,4019, 4:12 To: Scher, Deborah L. Subject: Following up - Virtual Clinical Trials Hi Deborah, Great speaking with you last week! I wanted to follow with a few things: I believe we landed on lung cancer as our first order of business. Was that your expectation? I know prostate cancer is also a focus for youiyour population. but I also know we have more pipeline innovations to consider in lung.lf that works, could you provide some dates times (say 5) in the mid to late August time frame that would work for a meeting between our teams?Could you share a one?pager with me that I could use to accurately socialize the concept with my internal stakeholders? Let me know what you think and we?ll work through next steps - Thanks, iblt??ll PharmD, MS Scienti?c Director, National Accounts Real World Value ti Evidence, Field Janssen Scienti?c Affairs LLC 1125 Trenton-Harbourton Rd. Titusville, NJ 08560 Mobile: {ms} lanssen Confidentiality Notice: This e?mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby noti?ed that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank youP Please consider the environment before printing this email (19-09764-F) - 000013 From: Scher, Deborah L. Sent: 17 Jul 2019 14:27:02 +0000 To: (?lm Subject: RE: RE: Following up - Virtual Clinical Trials Hilblithe same page. This one pager Is on my agenda for the call with Dr Is a high priority for him and I am sure he has much to share. Looking forward to working with you on this. Best, Deborah From: Sent: Wednesday, July 17, 2019 9:14 AM To: Scher, Deborah L. Subject: RE: Following up - Virtual Clinical Trials Hi Deborah, Correct -and I met yesterday to move the process forward. My ask about some additional information regarding virtual clinical trials was to inquire as to whether there was something approved to circulate for this ask. 0k if there?s nothing available, just thought to ask. We arrived on a list of stakeholders that we?d include and will look to you for dates in August once Dr. -gets backup and running after vacation! Thanks, hl?ii Emmi Pharmn. MS Scientific. Director. National Accounts Real World Value 8: Evidence, Field Janssen Scienti?c Affairs LLC 1 125 Trenton-I larbourton Rd. Titusville NJ 08560 Mobile:? Des?l?? Ehlt?} torusmrconr ianssenj? Confidentiality Notice: This e-mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient! you are hereby notified that any disclosure, copying. distribution. or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e?mail transmission in error, please reply to the sender, so that Johnson EL (19-09764-F) - 000014 Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you. ?Pleasa consider the environment before printing this email From: Scher, Deborah L. (Deborah.5cher@va.gov> Sent: Wednesday, July 2019 7:53 AM To:_ Subject: RE: Following up Virtual Clinical Trials Good morningmii?l Thank you very much for the call you organized and for your follow up. As a next step, my understanding was that-was going to organize your lung cancer subject matter experts and brief them on this potential collaboration. In parallel, i committed to reach out to our oncology leadership to discuss this specific opportunity. We would then arrange a call with everyone to discuss overall parameters of what we might do together. Dr._ has been on vacation but he and are scheduled to speak on Friday. Let me come back to you after he and have that conversation. With appreciation for your partnership, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary?s Center for Strategic Partnerships U.S. Department of Veterans Affairs SCSE From: one Date: Monday, Jul 15, 2019, 4:12 PM To: Scher, Deborah L. Subject: Following Lip - Virtual Clinical Trials Hi Deborah, Great speaking with you last week! I wanted to follow with a few things: 1. I believe we landed on lung cancer as our first order of business. Was that your expectation? I know prostate cancer is also a focus for youfyour population, but I also know we have more pipeline innovations to consider in lung. 2. If that works, could you provide some dates ,f times (say 5) in the mid to late August time frame that would work for a meeting between our teams? 3. Could you share a one-pager with me that I could use to accurately socialize the concept with my internal stakeholders? Let me know what you think and we?ll work through next steps - Thanks. (19-09764-F) - 000015 PharmD, MS Scienti?c Director, National Accounts Real World Value Evidence, Field Janssen Scienti?c Affairs LLC 1 125 Trenton-H arbourton Rd. Titusyille NJ 08560 MobiIerH?l Des also Hilts. .com iansseni?f Confidentiality Notice: This e?mail transmission may contain con?dential or legally privileged information that is intended onlyr for the individual or entity named in the e?mail address. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson Johnson can arrange for proper delivery, and then please delete the message from your int-ox. Thank you. ?PIease consider the environment before printing this email (19-09764-F) - 000016 From: Scher. Deborah L. Sent: 1? Jul 2019 17:53:11 +0000 To: liblt?l 1m lotto] [sceusi Subject: RE: Help with Provider locator under the Mission Act Thanks i will ask. From: -its.jnj.com> Sent: Wednesday, July 17. 2019 12:14 PM To: Scher, Deborah L. Subject: Help with Provider locator under the Mission Act Deborah Our team is wanting to support the Mission Act in the Oncology space specifically on the platform of provider and patient education. However in the website we cannot seem to pull down a search tool for the providers? When we pull down the drop down for ?Community Care outside the it is minimal at best. Is there a better place to look for this type of information? Hope you are having a great day. HEALTH can: L. _r'ritsjn'com I 'u . Con?dentiality Notice: This e?mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient. you are hereby noti?ed that any disclosure. copying. distribution. or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error. please reply to the sender, so that Johnson 8: Johnson can arrange for proper delivery. and then please delete the message from your inbox. Thank you. (19-09764-F) - 000017 From: Scher, Deborah L. Sent: 17 Jul 2019 21:43:43 +0000 To: this: IM Subject: FW: Help with Provider locator under the Mission Act Dear Here is the address I have been given. Providers in Regions 1 and 2 interested in joining CCN can contact Dptum at Hope this is helpful, Deborah From: m1 Sent: Wednesday, July 17, 2019 12:14 PM To: Scher, Deborah L. Subject: Help with Provider Iocator under the Mission Act Deborah Our team is wanting to support the Mission Act in the Oncology space specifically on the platform of provider and patient education. However in the website we cannot seem to pull down a search tool for the providers? lWhen we pull down the drop down for "Community Care outside the it is minimal at best. Is there a better place to look for this type of information? Hope you are having a great day. m: [m mum" my: sv-nr w. w: n2. 65.5. 'Ii?iE-j-I' L. Lam; 3-H 3. .J-fr'illS-jl'l Con?dentiality Notice: This e?mail transmission may contain con?dential or legally privileged inion?nation that is intended only for the individual or entity named in the e?mail address. If you are not the intended recipient. you are hereby noti?ed that any disclosure, copying. distribution. or reliance upon the contents of this e?mail is strictly prohibited. If you have received this email transmission in error, please reply to the senderr so that Johnson 8- Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you . (19-09764-F) - 000018 From: Scher, Deborah L. Sent: 18 Jul 2019 15:50:23 +0000 To: has) I- [also Subject: RE: RE: One Mind Thank you! Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary?s Center for Strategic Partnerships U.S. Department of Veterans Affairs From: . Date: Thursday. Jul 18, 2019, 11:34 AM To: Scher. Deborah L. Subject: RE: lOne Mind Give me the afternoon and I will find out. Tr! Carr_pits.'n'.com If, I ?1 H..- .4. .. Con?dentiality Notice: This e-mail transmission may contain con?dential or legally privileged iniormation that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby noti?ed that any disclosure. copying. distribution, or reliance upon the contents of this e?mail is strictly prohibited. If you have received this e-mail transmission in error. please reply to the sender, so that Johnson 8. Johnson can arrange for proper delivery. and then please delete the message from your inhox. Thank you From: Scher, Deborah L. Sent: Thursday, July 18, 2019 11:00 AM To: I lam -it5.jnj.com> Subject: One Mind Good Morning We had a very productive meeting with them yesterday, identifying several areas of potential collaboration both in research and for partnerships. They shared that was a major sponsor. Do you know what part of the company is supporting their efforts? (19-09764-F) - 000019 Thank you, Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary?s Center for Strategic Partnerships US. Department of Veterans Affairs (19-09764-F) - 000020 From: Scher, Deborah L. Sent: 27 Jul 2019 12:07:29 +0000 To: [@153 1- [term Subject: RE: Help to get in on the VA DOD Suicide Prevention conf Good morning I am sorry to hear this and hope Wendy can be helpful to you. Have a good weekend Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary?s Center for Strategic Partnerships US. Department of Veterans Affairs From: [sccusi - Date: Friday. Jul 26, 2019. 3:09 PM To: Scher, Deborah L. Subject: Help to get in on the VA DOD Suicide Prevention coni' Deborah i sent an email toMlto ask if she could help us get in to the VA DOD Suicide Prevention conference. it is sold out for external attendees. wcot in but and myself can?t get in. i have booked my hotel for the week using the code which was great. _il Qohatnouaqi?tmou -: Imilai Bitsinicom t; Ijl I. -- . Ia-l Confidentiality Notice: This e-mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient. you are hereby noti?ed that any disclosure, copying. distribution: or reliance upon the contents of this e-mail is strictly prohibited: If you have received this e-mail transmission in error1 please reply to the sender. so that Johnson 81 Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you. (19-09764-F) - 000021 From: Scher, Deborah L. Sent: 29 Jul 2019 19:20:54 +0000 To: libii?} 1m least] [scsusi Subject: RE: Follow up from our conversation Hi The U. 5 Chambeeriring Our Heroes, will be sending out invitations related to an Employer Challenge working group session next month. Would you be able to shar-_ ontact details with me? Thank you, Deborah From: -?Jits.jnj.com> Sent: Thursday, July 25, 2019 10:15 AM To: Scher, Deborah L. Subject: Follow up from our conversation Deborah Great touching base with you today. Here are some follow ups: 1. Attachment of the AHA Roundtable work that has been done for Mental Health in the Employer space. 2. _mltitle is VP of Global Health Services! Health and Wellness World Wide, let me know if you would like to speak to her about your Employer Challenge Initiative. 3. Finally the main VA person who is opposite Emil who could help you further understand the previous role is Is it Friday yet?? (53 hi: CLQE 31' L- .u I i . its.'n'.com . ..- lun Con?dentiality Notice: This e-mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby noti?ed that any disclosure, copying, distribution. or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error. please reply to the sender, so that Johnson 8- Johnson can arrange for proper delivery, and then please delete the message from your Thank you. (19-09764-F) - 000022 From: Scher, Deborah L. Sent: 31 Jul 2019 19:04:45 +0000 To: [one I- listen Cc: Subject: RE: RE: Best practices in the workforce around mental wellbeing and suicide prevention Excellent. Thank you Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretarys sCenter for Strategic Partnerships U.S. Department of Veterans Affairs From: Jhli?} loans. iniconP Date: Wednesday. Jul 31 2019 2:52 PM To: Scher Deborah Gov} Cam In ?01113" Subject: RE: Best practices in the woikf'orce around mental wellbeing and suicide prevention Deborah Thank you for reaching out, just connected with and she is the right person to send this invite to. have copied above for an appropriate handoff for this initiative. Thank you, -ml_ gohmolhllohmou mm com :1 {115sz mi: LI will?) liits.'n'.com -.--.- 2:311 Confidentiality Notice: This e-mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e?mail address. It you are not the intended recipient. you are hereby noti?ed that any disclosure. copying. distribution, or reliance upon the contents of this e?mail is strictly prohibited. If you have received this e-mail transmission in error: please reply to the sender, so that Johnson 8: Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you. (19-09764-F) - 000023 From: Scher, Deborah L. Sent: Wednesday, July 31, 2019 1:25 PM To: limit}? 1 l?tlL?L] Subject: FW: Best practices in the workforce around mental wellbeing and suicide prevention near? The Chamber of Commerce sent these out today. We are looking forward to learning from leading employers on this critical topic. Best, Deborah From: Eversole, Eric will Sent: Wednesday, July 31, 2019 11:49 AM Subject: Best practices in the workforce around mental wellbeing and suicide prevention Dear . The US. Chamber of Commerce Foundation-Hiring Our Heroes is working with the U.5. Department of Veterans Affairs to help identify and share best practices in the workforce around mental wellbeing and suicide prevention for the benefit of Veteran employees and all Americans. Because of the recognized commitment your leadership in this field has demonstrated, we are asking for your expertise in helping to build a consensus roadmap of the most effective programs and then to galvanize your fellow corporate leaders to pledge to implement them. As a first step, we will be holding a meeting in Washington on August 21 with a select group of your peers representing a diversity of industries to share insights, best practices, key metrics and outcomes measurements. We hope you will join us. On average, 20 Veterans die by suicide each day. VA research has determined that 6 of the 20 Veterans receive health care services from the VA system, and 14 do not. The VA has requested our partnership to help provide programs of broad and effective mental health support to those they do not reach. We know this is of critical importance to you and would value your expertise. We encourage participating leaders to use this meeting as a platform to educate, listen and learn from each other and to produce a Best Practices Program Roadmap that CEOs will be asked to publicly pledge to implement. Our agenda will also include vital next steps and identify potential obstacles in rolling this out to our broader membership. (19-09764-F) - 000024 The meeting will be held from 10:00 am. - 2:00 pm. at the U.S. Chamber of Commerce, 1615 Street NW, Washington D.C. 20062. Please respond at usehambercom by August 9, 2019. We look forward to seeing you there as we launch this mission critical work. Best regards, Eric Eversole President. Hiring Our Heroes Vite Provider?, US. ChamberofCommerc'e 1615 Street hii?i NW Washington. DC 20062 . of?ce mobile Loom (19-09764-F) - 000025 From: Scher, Deborah L. Sent: 15 Jul 2019 14:59:50 +0000 To: rota) 1m [scousi Cc: Breanna L. Wilson {Breanna.Wilson@va.gov] Subject: RE: Reflexion Health: Thank you Good Morning- Thank you for sharing this. The VA has offered Tele PT for several years. I am not sure if they have a needfare interested in expanding to outside vendors but will ask Bre to see if there is a POE for this company to connect with. Best, Deborah From: -@its.jnj.com> Sent: Monday, July 15, 2019 6:50 AM To: Scher, Deborah L. Subject: FW: Reflexion Health: Thank you Deborah Good Monday morning, I hope you had a great weekend. It was a great to relax a bit, although hot. have had the opportunity to spend some time with the company above {Reflexionl which J80 is partnering with since they play in the PT space for Hips and Knees. In addition they are founded by a War Veteran, under the West Foundation focused on helping people age in their home. When I better understood their solution, It sounded very close to the types of partnerships you are looking for around virtual health. This company has a totally virtual Physical Therapy solution with data analytics to back it up. They have recently been cleared to work with the VA and completed their studies with Duke Clinical Research Institution. They would like to speak with someone inside the VA that is not necessarily an end user. They have a number of questions to better understand how financially their model would be beneficial to the VA since reimbursement is not a focal point. Who would you suggest they start with? ?m1 Her-Lin CAM ?van I. .. _its.inj.com (19-09764-F) - 000026 -.. - . . . .- vii?. u'hrl .- g! . _i ,1 . Con?dentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e?mail address. If you are not the intended recipient. you are hereby noti?ed that any disclosure, copying. distribution. or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson 8? Johnson can arrange for proper delivery, and then please delete the message from your inhox. Thank you. From: lore) .llihiiai Sent: Wednesday, July 10, 2019 8:40 PM To: libit?i loud totem [sceusi [61(6) Ilfhii?) HE [opyus - ave Value Based Purchasing] niect: Reflexion Health: Thank you tots} Thank you so much for your time today and for your kind offer to introduce Reflexion Health to VA Leadership. To assist you in the introduction, I thought you might find the attached slide deck helpful, as it outlines the growth ofjoint replacements in the U.S. (as l?m sure you are more than aware}, highlights the costs of post-acute care, and details our service and technology. If you have any questions or concerns, I?d be delighted to answer them. Have a great night. We look forward to continued discussions. Best, Ml ECon?dentiality Notice; EThis email and its attachments may contain privileged and confidential information protected byE ifederal and state privacy laws. If you are not the intended recipient please contact the sender byi greply email and destroy all copies of the original email} EReflexinn Health inc. (19-09764-F) - 000027 From: Scher, Deborah L. Sent: 12 Jul 2019 14:34:40 +0000 To: lose I- [totem Cc: Wilson, Breanne L. Subject: RE: Re: Introduction to a great colleague Good morning It is an absolute pleasure to meet you by email. Always delighted to spend time with people thinks highly enough to recommend. [will ask Bre to find us some time to speak next week and look forward to getting to know you better. Warm regards, Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary?s Center for Strategic Partnerships U.S. Department of Veterans Affairs wovw.va.gov/scsp From: 40015.} Ioiigmai l.com2> Date: Thursda ,Jul I 1,2019. 8:03 Pu To: Cc: Deborah L. Subject: Re: Introduction to a great colleague-m Deborah, _aid, 1 have worked for INJ for 23 years. I just decided to leave as I want to pursue something I?m passionate about in my next chapter. Prior to JNJ, I spent 5 years as a paratrooper in the 82nd Airborne. I am passionate about providing our veterans with the best care and have had many experiences with the VA to shape my thoughts. In addition, many veterans - myselfincluded - suffer from orthopedic challenges given the hard nature of military service. That is an area where the VA has ever increasing demand and an area where I bring unique expertise. I?d love to connect to discuss the work your team is doing and to see if there are any opportunities for me to help. Re_ards, (19-09764-F) - 000028 Mobile: 704-953-3043 011 Jul 11, 2019, at 6:27 PM, giro IWMJ WTOIEI Deborah I am sending you this email with the intention of introducing you to a great colleague and friend. and I have worked together for a number of years and where a phenomenal team when it came to representing the total 18d approach. graduated from Georgetown, is a true leader and it a Veteran. He has worked for for 23 yrs. He has a great Lin kedln profile. We connected yesterday and he is very interested in speaking with you to gain some prospective on possible areas he could provide his expertise. I know you will find him to be full of great ideas and passion. I have copied him above so you both can find time to connect. I realize how much you have on your plate. thank you for any time you might be able to carve out to talk with [El Hope you had a great day today at our office. Thank you for all that you do for the on behalf of all our Veterans. -m1? 1? 7-1" -: -1. . .35. a .-.--..-., l. .: . . Con?dentiality Notice: This e-mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e-mail address. It you are not the intended recipient, you are hereby noti?ed that any disclosure. copying. distribution. or reliance upon the contents of this e?mail is strictly prohibited. If you have received this e-mail transmission in error. please reply to the sender, so that Johnson 8- Johnson can arrange for proper delivery. and then please delete the message from your inbox. Thank you. (19-09764-F) - 000029 From: Scher, Deborah L. Sent: 8 Jul 2019 20:36:59 +0000 To: Scher, Deborah L. Subject: FW: Meeting with 1&1 President of Neuroscience on 4/25? Attachments: RE: Meeting with President of Neuroscience on M2579, RE: New Office Factsheet, Re: Update, RE: Healthy Heros, RE: PDC for Spravato clinical implementation, RE: E-lntroduction., Spravato, image001.jpg, RE: Re: Thank you, RE: Meeting with JSIJ President of Neuroscience on RE: Meeting with 1&1 President of Neuroscience on 4,1251 RE: Confirmation for May 14th at 8:303rn with Dr. Stone quIKIU?I-l?kr?l?mi CARE ?it I (19-09764-F) - 000030 From: ihil?) T. Sent: 17 Apr 2019 13:37:18 +0000 To: Scher, Deborah L. Cc: Wilson, Breanna L. Subject: RE: Meeting with 1&1 President of Neuroscience on 4f25? Good morning Deborah, Please let me know if I should invite Mr. ?lm 0 the meeting on May 14th 8:309:00 am in Dr. Stone?s Office. If so, I will need his email address. I can get the office number from Standing by for your guidance. Thank vou, From: Scher, Deborah L. Sent: Wednesday, April 17, 2019 8:42 AM To: Wltbii?l @vagow Cc: L. 1(5) - va.gov>; D. USH Meeting Requests I@va.gov> Subject: RE: Meeting with 1&1 President of Neuroscience on 4(25? We will take care of the calendar invite and escorting Mr?ll?} Thank you, Deborah From: (Film _l Sent: Wednesday, April 17, 2019 8:40 AM To: Scher, Deborah L. ; Subject: RE: Meeting with 1&1 President of Neuroscience on 4/25? D. - va.gov>; VHA USH Meeting Requests V3. Wonderful! Should we send a calendar invite to Mr._ Do you have his email address? Or will your team take care of escorting him up? We will have the meeting in Dr. Stone?s office. From: Scher, Deborah L. Sent: Wednesday, April 17, 2019 8: 37 AM To: ?@1141 031(6) ?va. ov> mite) Eva. gov}; m_ o. um team we Eva-aw lS?ubject: RE: Meeting with 1&1 President of Neuroscience on 4/25? Good Morning (19-09764-F) - 000031 This is confirmed. I will also join the meeting and send advance materials. Thank you for setting aside time for this. Best, Deborah From: m1 Sent: Tuesday, April 16, 2019 8:23 AM To: Scher, Deborah L. (Debora Cc: L. (VHACOlribx?f Eva.gov>; D. Felan, lt?l?l?l Evagow Subject: RE: Meeting with 13d President of Neuroscience on 4(25? Good morning Deborah Apologies for the delay. Dr. Stone is available on May 14th from 3:30?9:00am. Would that work? I will put a hold on the calendar for now. Thanks! From: Scher, Deborah L. Sent: Tuesday, April 16 2019 5:38 AM To: [m ?hm @va.gov> Cc: L. Elvagow Subject: RE: Meeting with 1&1 President of Neuroscience on 4/25? Good Morning rota! an- I know Dr. Stone?s schedule is packed. Any chance you might be able to find a 30 minute spot on one of these days below? Thank you very much, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary?s Center for Strategic Partnerships US Department of Veterans Affairs From: Scher, Deborah L. Date: Thursday, Apr 11 2019 4:28 PM To: 4?th li?lvaeov?} Cc: -MI L. {Elm} lavagous Subject: RE: Meeting with 180 President of Neuroscience on #25? Hi Mr. (Diff?) would like to work around Dr. Stone?s schedule. Might he have a 30 minute opening on May 23, the week of May 5th or May14th? Thank you very much in advance for your assistance, Deborah (19-09764-F) - 000032 From: Scher, Deborah L. Sent: Wednesday, April 10, 2019 2:21 PM To: Ill?t?} Mll?ll?} Stone, Richard A., MD Cc: L. (yHAc01_va.oys Subject: RE: Meeting with 18d President of Neuroscience on 4/25? Hi Thank you for checking and getting back to me so quickly. I will find out when he will next be in DC. Best, Deborah From: Sent: Wednesday, April 10, 2019 2:1? PM To: Scher, Deborah L. Stone, Richard A., MD Cc: L. [foot @yagoy: Subject: RE: Meeting with 13d President of Neuroscience on 4.05? Hi Deborah - Is that the only time he will be in Unfortunately Dr. Stone is going to be at an all day offsite meeting April 23-25? Thanks! From: Scher, Deborah L. Sent: Wednesday, April 10, 2019 12:13 PM To: Stone, Richard A., MD Cc: ?hlif? lkthaeoy?e; lih??l L. (VHACO) - ya.-oy> Subject: Meeting with J80 President of Neuroscience on 4,125? Dear Rich: Mr. will be in DC on April 25"h and would like to spend 30 minutes with you if possible sometime between 2-5. He was on the call with you and Secretary Wilkie about Sprayato. The purpose would be to provide a brief update as to all the progress 1&1 has made to date with the VA since the launch of Sprayato and then a discussion of what else you need or want to better serve the Veterans with Depression or Suicide ldeation. Thank you, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary?s Center for Strategic Partnerships US Department of Veterans Affairs Follow us on Twitter (19-09764-F) - 000033 From: this} I- islet] Sent: 7 May 2019 20:42:311 +0000 To: Scher, Deborah L. Subject: RE: New Office Factsheet Sounds like a great plan. just got off the phone with-from Armor and I cannot believe it but she lives in my hometown in NY. Her kids went to the same High School I did. What a small world. We talked for 40 minutes and I think there is a possible avenue to go down around education to the VA around Spravato. Will be reaching out to my brand team to give them some highlights. . But in the meantime, WEI is going to find out who the contact was tha-had prior to her moving over to Hub. Love it when I can uncover new opportunities. Thank you so much for the introduction. I?mm llohmmt-tgc?lth can sueiiILI-?i inr. Con?dentiality Notice: This e-mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipientI you are hereby notified that any disclosure. copying. distribution. or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error. please reply to the sender, so that Johnson 8- Johnson can arrange for proper delivery. and then please delete the message from your inbox. Thank you. From: Scher, Deborah L. (Deborah.5cher@va.gov> Sent: Tuesday, May 07, 2019 4:25 PM To: use; I -llits.jnj.com> Subject: RE: New Office Factsheet Dear-m] Thank you for making the time to review this and to share your feedback. It means so much to me! We plan to post this on our website which should be launched very soon. (19-09764-F) - 000034 Yes, would be delighted if you might share this with your Corporate Equity team. I would welcome their feedback as well. With appreciation, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary's Center for Strategic Partnerships US Department of Veterans Affairs Follow us on Twitter From: @its.ini.com> Sent: Tuesday, May 7, 2019 3:49 PM To: Scher, Deborah L. Subject: RE: New Office Factsheet Deborah This is excellent and so much clearer than the last version you sent me. How do you plan distributing this to the masses? Will you post this on Twitter! Linkedin as a way to drive people to your site? Will you send out via personal emails? When can I send this along to our Corporate Equity team? I will be curious to see how they Will react to it? It certainly gets your juices flowing with ideas. WELL mist?au? ?En-l1? mat '3?le M5 IhiL (19-09764-F) - 000035 Con?dentiality Notice: This e-mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e?mail address, If you are not the intended recipient. you are hereby noti?ed that any disclosure, copying. distribution, or reliance upon the contents of this e?mail is strictly prohibited, if you have received this email transmission in error, please reply to the sender, so that Johnson 8. Johnson can anange for proper delivery. and then please delete the message from your lnbox. Thank you. From: Scher, Deborah L. Sent: Tuesday, May 2019 2:44 PM To: [Mini 1] Emu Subject: New Office Factsheet Dear Some time ago, you were kind enough to review our website materials in draft and pointed out we needed more information on how to partner. We've recently created the fact sheet attached and wondered if we might impose on you again to provide feedback. Thank you in advance, Deborah (19-09764-F) - 000036 From: l- Sent: 12 May 2019 12:26:31 +0000 To: Scher, Deborah L. Subject: Re: Update Hi Deborah Thanks for your note. Yes, the Suicide event was very eventful and moving. I pointed out that -- while its the very tragic situation that brings us here tonight -- it really was an evening of Hope. Hope that coming together, we could make a *big difference* and save lives. And that resonated with everyone. Thanks for sending me the additional potential names. I don?t know them but will do some homework and let you know. Delighted that you're giving a keynote at the VA Healthcare Conference I'm sure that it will be great! And you will enjoy meetin- 1&1 is a large complex organization so I'll just explain. I am the Global Head of Neuroscience the North American *Commercial* Neuroscience. So we wok closely together {eg my team discovered/developed Spravato as a novel, rapid acting antidepressant; his group is involved in commercializing it). Most importantly, he is also a veteran, and we work closely on a number of Veteran's initiatives, including our "Healthy Heroes Project" with the VA Take care From: Scher. Deborah L. {Deborah.Schert??vagov} Sent: Sunday, May 12, 2019 6:42 AM To: Subject: RE: Re: Update Good Morning Congratulations! lam so pleased to hear the dinner went well and you were able to recognize such a broad coalition of supporters. You have clearly created an important focal point for their efforts that I hope we can build on. Thank you for including Veterans in your remarks. We are fortunate to have and her endless, passionate and determined commitment to this cause, leading the VA's Office of Suicide Prevention. Now to find her a national partner! (19-09764-F) - 000037 As an update, Drs- an . both declined. Dr. ?was interested but could only commit 50% of his time. We have recently reached out to Genera (bi-t6) le6) I Ifrom the National Coalition of Health Care Purchasers and Dr? from Semperfi. Would you haye insights on any of them? lam looking forward to seeing Illzii?l at the VA Healthcare 2019 conference tomorrow (my first keynotell, and to meeting Mr. [ibil?i lihli?l on Tuesday. With much appreciation for your ongoing partnership, Deborah Sent with BlackBerry Work From: ibil'?i Mi its.ini.com> Date: Saturday, May 11, 2019, 3:30 AM To: Scher, Deborah L. Subject: Re: Update Hi Deborah Hope all is well; just touching base hope the search is going well At the Suicide Prevention Gala went *extremely well* . We recognized a number of media and sports personalities {in addition to researchers) who have been committed to making a difference. These included Anderson Cooper, Kate Snow (NBC), SF 49ers player Solomon Thomas, etc. And David Axelrod, and SF tigers CEO (who introduced Anderson Cooper and the Thomas family, respectively) also spoke about their losses to suicide During my comments I called out the tragic situation of our losing 20 heroes/day, and how we need to come together as a society to make a real difference. I also had some good conyersations with currentfformer VA folks I know, including and (the latter now with George HW Bush Institute i believe). Finally mentioned having had a good discussion with you, and indicated that he was going to be speaking. I encouraged him to look at it carefully Best (19-09764-F) - 000038 From: Scher, Deborah L. Sent: 14 May 2019 10:01:28 +0000 To: Clancy, Carolyn Subject: RE: Healthy Heros Oh boy. Happy to brief you at your convenience. Hope the day goes well. We will miss having you with us! Deborah Deborah Lafer Scher From: Clancy, Carolyn (19-09764-F) - 000039 Date: Monday. May 13, 2019, 8:05 PM To: Scher, Deborah L. Cc: Stone, Richard A, MD _"va.gov> Subject: RE: POC for Spravato clinical implementation Thanks for the email regarding Spravato, Deborah! There is a team working on this as there are many' important aspects to consider as we roll out safe delivery of care. Adding?to the email as the POC/?Champion. - look forward to continued work on careful implementation! Hope this helps, Deborah, and feel free to contact us for any additional needs. Sent with BlackBerry Work From: Scher, Deborah L. Date: Thursday, Mar 21, 2019, 3:01 PM To: Boyd, Teresa D. Carroll, David Cc: Stone, Richard A, MD Subject: PDC for Spravato clinical implementation Good Afternoon: With advance apologies because I am not sure exactly where to address this question. A senior team from Ed was visiting with us to discuss several partnership opportunities. In our meeting, they commented on how quickly the two organizations have moved to make this drug available, and noted that the key Pharmacy leads have connected and an implementation plan is in place. However, given the complex process for administering this product, they asked if we might help identify the VA PDC for the clinical implementation. Their field staff is ready to provide training and support, but are not sure what the plans are in general, which locations might be targeted and who they should be interfacing with from the VA. (19-09764-F) - 000041 Dr. Bovd or Dr. Carroll, are either of you the right POC for this effort? Thank you very much in advance for vour assistance, Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretarv's Center for Strategic Partnerships US Department of Veterans Affairs Follow us on Twitter (19-09764-F) - 000042 From: Sent: 22 Mar 2019 16:40:08 +0000 To: 00(6) Deborah L. Cc: ll?ll?Ll {me} Ashleigh Subject: RE: E-lntroduction., Spravato - Welcome back home to the Bay Area! l?m sitting about an hour away from you {depending on trafficll, in Menlo Park. 😊 Below I?ve listed the times have available for a call this coming week please let me know what works best for you and others on your team and we can set something up. Best, Tue 3/26 anytime after 11:30 am Wed 3/2? anytime after 10 am Thu 3/28 10~12p, anytime after 1p Fri 3,129 843, anytime after 10a From: Sent: Friday, March 22, 2019 9:30 AM To: REFS. 15} Evagovrv; Scher, Deborah L. Cc: I- [emu [scsus1 @161 [scsus1 Barry, Ashleigh Subject: RE: EelntroductionuJ 8d Spravato ME Sorry for the delayed response, I was traveling back to California from DC and can empathize with early calls on the west coast! live in Livermore. lam thrilled that Deborah made the introduction after our meeting with her in DC yesterday. I have attended each of the Anywhere 2 Anywhere meetings and have often heard your name referenced as the expert leading the charge for PDSI and the complex problems program. I currently work closely with the FEM and am responsible for coordinating 18:] resources/personnel as it relates to clinical, operational, value evidence, and healthcare delivery within the VA setting. I think a great starting point, would be to hop on a call next week to understand your needs, perhaps share some insights we have gained thus far, and ideate around important operational considerations that this new treatment demands. We want to ensure an optimal care experience and workflow for our nation?s veterans suffering with TRD and offer assistance where appropriate. Please let me know if there is a time that works for your schedule and thanks for caring for our veterans. (19-09764-F) - 000043 Director, Strategic Accounts Notional Federal Team Strategic Customer Group Johnson Johnson Health Core Systerns Johnson a Johnson Supports Our Troops 8: Veterans sci vices Joinseo uifiohimm Johnson Notice Will .3 ?He'll" for? 'rlirih?' .??iia 'i-ri iru'iw I: 'Lr' twin-intros: or .f-irrm Harri-1.? ir .iir.? View" .r ion Jr'_ our .'rri' 'r'li mam-r. H's-if .?Jj?l (unit-i}- Dir." 5' Girl. ?(ii ,?r'l'ru?i i1?? 'r .- in: inf; MW in? for sen-Yr- so roar minister at mi" arr-woe m: rem- zoo Joe's? ?it} n?rr message new} anti-.- Frill?. From: I Sent: Thursday, March 21, 2019 1:27 PM To: Scher, Deborah L. I Subject: RE: E-lntroduction., Sci Spravato Thank you, Deborah. 8! 1 team let me know when we can arrange a phone call to discuss how best to start moving this process forward. Please bear in mind i am California-based, so morning meetings earlier than 10 am ET are tough for me to make. Thanks, and looking forward to working with you. Best, *Hl?li I R. MD, MPP, MHS National Director. Drug Safety Initiative Co?Director. Care for Patients With Complex Problems {Eli}P Associate Director. Northeast Program Evaluation Center Office of Mental Health and Suicide Prevention Department of Veterans Affairs Assistant Clinical Professor of Yale School of Medicine cell email: I Connect to: PDSI Horne PDSI Management System (19-09764-F) - 000044 From: Scher, Deborah L. Sent: Thursday, March 21, 2019 1:05 PM To: $5335} Evagov?} Cc: the) ?(Elm Ella} l- Barry, Ashleigh Subject: E-lntroduction., 8d Spravato Dear By copy of this email, it is my pleasure to introduce you to Ilhill?) ??th Im Wild and EM from 8: J. They will be leading the effort to connect you with the] 3d team assigned to support VHA with the effective clinical implementation of this new program. I know you will enjoy working with them and their colleagues. Thank you all for your leadership in making this program available to Veterans. With appreciation, Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary?s Center for Strategic Partnerships US Department of Veterans Affairs Follow us on Twitter (19-09764-F) - 000045 From: Scher, Deborah L. Sent: 10 Apr 2019 12:46:59 +0000 To: [one .1 than Cc: Subject: RE: Re: Thank you Good morning: So sorry your journey was not a quick one. Glad you were pleased with the events of the day. Could we have a quick touch base call around 1115 or 1 130 this morning? And then yes, happy to take forward the meeting on the 25th (time frame he is available?)and our other next steps. Thank you, Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary's Center for Strategic Partnerships US Department of Veterans Affairs From: Date: Wednesday, Apr 10, 2019, 8:08 AM To: Scher, Deborah L. sDeborah.Schenfallvagow entails} . Subject: Re: Thank you wheel-come Deborah, You beat me to it. My flight home had all kinds of tiny delays which ultimately got me home at 1 1pm. But every minute of my trip was totally worth it. @and I were also grateful things got moved back and agreed it totally worked in our favor. We would have never gotten that amount oftime if it was prior to the press release. The level of conversation and ideas that were exchanged with both you and Dr. Clancy to Dr. Stoffels and? was inspirational. I will be closing the loop as to were we landed for follow up meetings with Melinda and Dr. Stoffels today. In the meantime if it is at all possible can we try to see if you and Dr. Stone might be available to meet with our NS President Ilmtl?) and myself for 30minutes on April 25th anytime between 2-5pm? -was on the original phone conversation with Secretary Wilkic, Dr. Stone and our CEO Alex Gorsky. (19-09764-F) - 000046 The purpose would be to provide a brief update as to all the progress we have made to date with the VA since the launch of Spravato and then a simple ask of what else Dr. Stone needs or wants to better serve the Veterans with Depression or Suicide Ideation. am very flexible tomorrow to connect live to discuss next steps together if that works with your schedule. Have a great day, it is beautiful here in Charlotte and hope it is the same in Washington DC. Sent from my iPltone Johnson 8: Johnson Healtheare Systems Field Director Federal Teamf Strategic Engagement ram 3* On Apr 10. 2019. at 7:39 AM, Seher. Deborah L. {DeborahSelter@va.gov} wrote: Good morningl?lia} landl?l?l 2' Thank you very much for all of the time and effort you spent arranging for our meeting yesterday. It was clear that you both worked very hard to secure the tinte and make the case for why a meeting would be valuable. 3' Dr. Clancy and I both enjoyed the conversation and are eager to pursue the follow up meetings we identi?ed. On a personal note, I thought the revised schedule actually worked in our favor and was grateful for the additional opportunity to get to know both ofyou better. I) Te Let?s schedule a time to speak in the next day or so to ?nalize next steps. 33- With appreciation. T) Deborah Deborah Lafer Seher 3* Executive Advisor to the Secretary Secretary's Center for Strategic Partnerships 1) US Department of Veterans Affairs :5 (19-09764-F) - 000047 From: Scher, Deborah L. Sent: 16 Apr 2019 14:32:50 +0000 To: m] Cc: L. t21to_l Ilhi?i' item Subject: RE: Meeting with President of Neuroscience on 4f25? Hi Thank you very much. I will reach out to confirm and come back to you. Have a good day. Deborah Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary's Center for Strategic Partnerships US Department of Veterans Affairs From: Ilbl?i} Cc: L. (VHACD) _@va.gov> Subject: RE: Meeting with President of Neuroscience on 4/25? Good Morning and Jen: i know Dr. Stone's schedule is packed. Any chance you might be able to find a 30 minute spot on one of these clays below? Thank you very much, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary's Center for Strategic Partnerships US Department of Veterans Affairs From: Scher, Deborah L. Date: Thursday, Apr 11, 2019, 4:23 PM (19-09764-F) - 000048 To: (?Hal va. ov> Cc: bllti} L. {tbjt?'} ?lvagov} Subject: RE: Meeting with 18;] President of Neuroscience on Hi Mr. lhll?l would like to work around Dr. Stone's schedule. Might he have a 30 minute opening on May 2-3, the week of May 6th or Thank you very much in advance for your assistance, Deborah From: Scher, Deborah L. Sent: Wednesday, A ri 10 2019 2:21 PM To: va.gov>; Stone, Richard A., MD (Richard.Stone2@va.gov> CE: L. (VHACD) Subject: RE: Meeting with 18.0 President of Neuroscience on Hi- Thank you for checking and getting back to me so quickly. I will find out when he will next be in DC. Best, Deborah From: (baa: m] Sent: Wednesday, April 10, 2019 2:17 PM To: Scher, Deborah L. <0eborah.5cher@va.gova; Stone, Richard A., MD Cc: hll?l [Ml L. (VHACO) va.ov:> Subject: RE: Meeting with 1&1 President of Neuroscience on 4,125? Hi Deborah Is that the only time he will be in Unfortunately Dr. Stone is going to be at an all day offsite meeting April 23?25? Thanks! From: Scher, Deborah L. Sent: Wednesday, April 10, 2019 12:13 PM To: Stone, Richard A.. MD Cc: L. 3 va.ov:> Subject: Meeting with 1&1 President of Neuroscience on 4,?25? Dear Rich: Mr. will be in DC on April 25th and would like to spend 30 minutes with you if possible sometime between 2-5. He was on the call with you and Secretary Wilkie about Spravato. The purpose would be to provide a brief update as to all the progress J80 has made to date with the VA since the launch of Spravato and then a discussion of what else you need or want to better serve the Veterans with Depression or Suicide Ideation. (19-09764-F) - 000049 Thank you, Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary's Center for Strategic Partnerships US Department of Veterans Affairs Follow us on Twitter (19-09764-F) - 000050 From: {1126) ibii?) T. Sent: 17 Apr 2019 13:37:18 +0000 To: Scher, Deborah L. Cc: Wilson, Breanna L. Subject: RE: Meeting with 1&1 President of Neuroscience on 4f25? Good morning Deborah, Please let me know if I should invite Mr_ to the meeting on May 14th 8:309:00 am in Dr. Stone?s Office. If so, I will need his email address. I can get the office number from Standing by for your guidance. Thank you, From: Scher, Deborah L. Sent: Wednesday, April 17, 2019 8:42 AM To: my item: buagow Cc: L. (vnaco) Ilbii?) l- 0. jvagow; WJ [lbll?l Elvagow; VHA USH Meeting Requests [(111931 [{hu?i ??ivagow Subject: RE: Meeting with 1&1 President of Neuroscience on 4/25? We will take care of the calendar invite and escorting Thank you, Deborah From: (Mim- _1 Sent: Wednesday, April 17, 2019 8:40 AM To: Scher, Deborah L. Cc: L. (VHacoHWi?) @vagovs; Rota} I- o. llbl'l?) Evagow; VHA USH Meeting Requests (VHAUSHMeetingReouests@ua.gov> Subject: RE: Meeting with 1&1 President of Neuroscience on 4/25? Wonderful! Should we send a calendar invite to Mr Do you have his email address? Or will your team take care of escorting him up? We will have meeting in Dr. Stone?s office. From: Scher, Deborah L. Sent: Wednesday, April 17, 2019 8:37 AM To: Il?ii?l I Pva.gov> . L. bra: .- o. vasov> Subject: RE: Meeting with 1&1 President of Neuroscience on 4/25? Good Morning (19-09764-F) - 000051 This is confirmed. I will also join the meeting and send advance materials. Thank you for setting aside time for this. Best, Deborah From: m1 Sent: Tuesday, April 16, 2019 8:23 AM To: Scher, Deborah L. Cc: (vHinicoubum va. ov>; (bii?i o. .ihl?i} @va.gov>; Felan, ll?ll?l I one) va.gov> Subject: RE: Meeting with 13d President of Neuroscience on 4(25? Good morning Deborah Apologies for the delay. Dr. Stone is available on May 14th from 3:30?9:00am. Would that work? I will put a hold on the calendar for now. Thanks! From: Scher, Deborah L. Sent: Tuesday, April 16, 2019 5:38 AM To: Ilbll?i 4mm) va.gov> Cc: L. (UHACD WE va. ov> Subject: RE: Meeting with 1&1 President of Neuroscience on 43?25? nu;- Good Morning and I know Dr. Stone?s schedule is packed. Any chance you might be able to find a 30 minute spot on one of these days below? Thank you very much, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary?s Center for Strategic Partnerships US Department of Veterans Affairs From: Scher, Deborah L. Date: Thursday, Apr 11, 2019, 4:28 PM To: Iibl?i) I thii?} l@va.gov> Cc: -MI L. (vHAcoilh??i l?va.gov> Subject: RE: Meeting with Ed President of Neuroscience on 4i25? Hi Mr. (him) would like to work around Dr. Stone?s schedule. Might he have a 30 minute opening on May 23, the week of May 5th or May14th? Thank you very much in advance for your assistance, Deborah (19-09764-F) - 000052 From: Scher, Deborah L. Sent: Wednesday, A ri 10 2019 2:21 PM To: hll?l va.gov>; Stone, Richard A., MD Cc: L. (VHACDJ @vamvs Subject: RE: Meeting with 1&1 President of Neuroscience on 4/25? Hi Thank you for checking and getting back to me so quickly. I will find out when he will next be in DC. Best, Deborah From: Sent: Wednesday, April 10, 2019 2:1? PM To: Scher, Deborah L. Stone, Richard A., MD Cc: L. Pita) 'va._ov> Subject: RE: Meeting with 13d President of Neuroscience on 4.05? Hi Deborah - Is that the only time he will be in Unfortunately Dr. Stone is going to be at an all day offsite meeting April 23-25? Thanks! From: Scher, Deborah L. Sent: Wednesday, April 10, 2019 12:13 PM To: Stone, Richard A., MD Cc: ?mm dew va.gov>; L. va.-ov> Subject: Meeting with J80 President of Neuroscience on 4,125? Dear Rich: Mr. will be in DC on April 25"h and would like to spend 30 minutes with you if possible sometime between 2-5. He was on the call with you and Secretary Wilkie about Spravato. The purpose would be to provide a brief update as to all the progress 1&1 has made to date with the VA since the launch of Spravato and then a discussion of what else you need or want to better serve the Veterans with Depression or Suicide ldeation. Thank you, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary?s Center for Strategic Partnerships US Department of Veterans Affairs Follow us on Twitter (19-09764-F) - 000053 From: ?31(5) lhll?l T. Sent: 24 Apr 2019 18:05:11 +0000 To: Scher, Deborah L.;Wilson, Breanna L. Subject: RE: Confirmation for May 14th at 3:30am with Dr. Stone Working it, thanks From: Scher, Deborah L. Sent: Wednesday, A ril 24, 2019 12:31 PM To: Ella} I bll?l va.gov>; Wilson, Breanne L. Subject: FW: Confirmation for May 14th at 8:30am with Dr. Stone and ?re: Please work with to finalize and send out this invite. It is already on Dr. Stone?s calendar. m1 is his POC. Our office should make arrangements with Security please and welcome the J80 leadership that morning. The meeting will take place in Dr. Stone?s office. and I will attend. Thank you, Deborah From: Jhli?} 'bitsinrcoms Sent: Wednesday, April 24, 2019 11:40 AM To: Scher, Deborah L. (Deborah.5cher@va.govh Subject: Confirmation for May 14th at 813Ciam with Dr. Stone Deborah Ijust heard back from our President at Janssen Neuroscience over Spravato and he is confirmed to be available to meet with Dr. Stone on May 14th at 8:3(Jam. Can you send me an outlook invite so we have the logistics and then I can send them along to- So glad we will be together on both the 13th and the Hope you are having a good day today. Wt?SO?aug?Orl?iOhora} ?Mil -- r- -. nu: I'll . .- (19-09764-F) - 000054 Con?dentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e?mail address, If you are not the intended recipient. you are hereby noti?ed that any disclosure, copying. distribution, or reliance upon the contents of this e?mail is strictly prohibited. If you have received this email transmission in error. please reply to the sender, so that Johnson Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you . (19-09764-F) - 000055 Sent: 17 Jul 2019 21:24:25 +0000 To: than [one] Subject: FW: Help with Provider Iocator under the Mission Act Dear Please see the email From: Sent: Wednesday, July 17, 2019 4:10 PM Subject: RE: Help with Provider Iocator under the Mission Act hello- Providers in Regions 1 and 2 interested in joining CCN can contact Dptum at ng@optum.com. lhll?) (?lial MA Management Analyst DUSH for Community Care From: l@its.ini.com> Sent: Wednesday, Iulyl 17, 2019 12:14 PM To: Scher, Deborah L. Subject: Help with Provider Iocator under the Mission Act Deborah Our team is wanting to support the Mission Act in the Oncology space specifically on the platform of provider and patient education. However in the website we cannot seem to pull down a search tool for the providers? When we pull down the drop down for "Community Care outside the it is minimal at best. Is there a better place to look for this type of information? Hope you are having a great day. nun 1n rm? 31:1? aw. .mj .: Raver "bktajanm (19-09764-F) - 000056 Con?dentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e?mail address, If you are not the intended recipient. you are hereby noti?ed that any disclosure, copying. distribution, or reliance upon the contents of this e?mail is strictly prohibited. If you have received this email transmission in error. please reply to the sender, so that Johnson Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you . (19-09764-F) - 000057 From: 1m tetra] Sent: 18 Jul 2019 20:25:55 +0000 To: Scher, Deborah L. Subject: RE: One Mind Deborah just found out the person I need to connect with to find out more around ONE MIND. have a call set up for tomorrow afternoon. -mm lec-u-ugdimcn HEM in Lane a m: .Ir -- I .. Confidentiality Notice: This email transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e?mail address, If you are not the intended recipient. you are hereby noti?ed that any disclosure, copying. distribution, or reliance upon the contents of this email is strictly prohibited. If you have received this email transmission in error. please reply to the sender, so that Johnson 8- Johnson can arrange for proper delivery. and then please delete the message from your inbox. Thank you. From: Scher, Deborah L. <0eborah.Scher@va.gov> Sent: Thursday, July 18, 2019 11:00 AM To: Itbtl?il Subject: One Mind Good Morning- We had a very productive meeting with them yesterday, identifying several areas of potential collaboration both in research and for partnerships. They shared that 130 was a major sponsor. Do you know what part of the company is supporting their efforts? Thank you, Deborah Deborah Lafer Scher Executive Adviser to the Secretary Secretary?s Center for Strategic Partnerships U.S. Department of Veterans Affairs SCSE (19-09764-F) - 000058 From: Wilson, Breanna L. Sent: 22 Jul 2019 12:42:42 +0000 To: l?li?l Deborah L. Subject: RE: Re: Following up Virtual Clinical Trials Good morning, As of right now the only time in the next two weeks that works for Deborah and Dr. is Monday 29 July 2019 at 4:00pm. have forwarded a calendar invite from Debora h's schedule. If this time doesn?t work we will need to look at dates in the second week of August. Thank you, Bre Wilson Portfolio Manager Secretary?s Center for Strategic Partnerships Office of the Secretary U.S. Department of Veterans Affairs 810 Vermont Ave, NW Washington, DC 20420 Office: (202] 461-0165 Mobile: (202)412-4487 Follow us on Twitter Or on the web: From: Sent: Monday, July 22, 2019 7:24 AM To: Scher, Deborah L. Cc: Wilson, Breanna L. Subject: Re: Following up - Virtual Clinical Trials Hi Deborah, Thanks for the follow up! Bre, can you provide 5 datesitimes that work for the calendars of those involved? I think it will easier to find a 30min slot on a shorter time frame for multiple people. Open to feedback on this. That will give me something to circulate our team. Have a nice week! Phil Get Outlook for Android (19-09764-F) - 000059 From: Scher, Deborah L. Sent: Monday, JulyI 22, 6:45 AM Sub'ect: RE: RE: Following up - Virtual Clinical Trials To: Cc: Wilson, Breanna L. Good morning Phil: I hope you had a nice weekend and managed to stay cool. I had a brief conversation with 0LWIUH Friday. He is eager to move forward on this. A helpful next step would be to arrange a call with a small group of people to share thoughts on how we might best to do a first virtual trial together in lung cancer and then arran a follow working session. Ere can coordinate the VA participants which would include {him} and me. Who should she work with on your team? Would be great to get this scheduled for this week or the early part of next week. Thank you very much for your partnership on this, Best, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary?s Center for Strategic Partnerships U.S. Department of Veterans Affairs From: Date: Wednesday, Jul 17, 2019, 9:19 AM To: Scher, Deborah L. Subject: RE: Following up - Virtual Clinical Trials Hi Deborah, Correct and I met yesterday to move the process forward. My ask about some additional information regarding virtual clinical trials was to inquire as to whether there was something approved to circulate for this ask. OK if there's nothing available. just thought to ask. We arrived on a list of stakeholders that we'd include and will look to you for dates in August once Dr- gets back up and running after vacation! Thanks, PharmD, MS Scienti?c Director, National Accounts Real World Value 8% Evidence, Field (19-09764-F) - 000060 Janssen Scienti?c Affairs LLC 1125 Trenton-Harbourton Rd. Titusville NJ 08560 Mobile! Desk: (bite; [one '@its.ini.com Confidentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient. you are hereby noti?ed that any disclosure, copying. distribution. or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error. please reply to the sender. so that Johnson Johnson can arrange for proper delivery. and then please delete the message from your inbox. Thank you.P Please consider the environment before printing this email From: Scher. Deborah L. Sent: Wednesda . July 2019 ?:53 AM To: Subject: RE: Following up - Virtual Clinical Trials Good morning Phil: Thank you very much for the call you organized and for your follow up. As a next step. my understanding was that?was going to organize your lung cancer subject matter experts and brief them on this po ential collaboration. In parallel. I committed to reach out to our oncology leadership to discuss this specific opportunity. We would then arrange a call with everyone to discuss overall parameters of what we might do together. Dr_has been on vacation but he and I are scheduled to speak on Friday. Let me come back to you after he and have that conversation. With appreciation for your partnership. Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary's Center for Strategic Partnerships U.S. Department of Veterans Affairs novi?scsg . [coerce] Date: Monday. Jul 15. 2019. 4:12 PM To: Scher, Deborah L. Subject: Following up - Virtual Clinical Trials Hi Deborah. Great speaking with you last week! I wanted to follow with a few things: I believe we landed on lung cancer as our ?rst order of business. Was that your expectation? I know prostate cancer is also a focus for youiyour pepulation. but I also know we have more (19-09764-F) - 000061 pipeline innovations to consider in lunglf that works. could you provide some dates I times (say 5) in the mid to late August time frame that would work for a meeting between our teams?Could you share a one?pager with me that I could use to accurately socialize the concept with my internal stakeholders? Let me know what you think and we?ll work through next steps - Thanks, PharmD. MS Scienti?c Director, National Accounts Real World Value Evidence. Field Janssen Scienti?c Affairs LLC 1125 Trenton?Harbourton Rd. Titusville NJ 08560 Mobile: i133} ianssen? Confidentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e?mail address. if you are not the intended recipient. you are hereby noti?ed that any disclosure, copying. distribution. or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error. please reply to the sender. so that Johnson at Johnson can arrange for proper delivery. and then please delete the message from your inbox. Thank you.F? Please consider the environment before printing this email (19-09764-F) - 000062 From: lime} totem Sent: 19 Jul 2019 19:08:53 +0000 To: Scher, Deborah L. Subject: RE: One Mind Deborah I had a chance to dig into 1&1 and found out the best person for you to connect with around our involvement with ONE MIND is -or Dr. looks like most of our involvement has been on the side of our business. Since I know you have connected with both of them personally I thought it best to let you take it from here, versus me trying to be the middle person. Happy Friday, PILAHH (Lift Illt. . bye}. . - o; mun-5' 1.. Con?dentiality Notice: This e-mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient1 you are hereby noti?ed that any disclosure, copying, distn'bution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson 8. Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you. From: Scher, Deborah L. Subject: One Mind Good Morning- We had a very productive meeting with them yesterday, identifying several areas of potential collaboration both in research and for partnerships. They shared that 130 was a major sponsor. Do you know what part of the company is supporting their efforts? Thank you, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretary?s Center for Strategic Partnerships U.S. Department of Veterans Affairs SCSQ (19-09764-F) - 000063 From: Sent: 29 Jul 2019 17:13:03 +0000 To: Scher, Deborah L. Subject: RE: Following up - Virtual Clinical Trials That?s perfect, thank you! PharmD, MS Scientific Director, National Accounts Real World Value Evidence, Field Janssen Scienti?c Affairs LLC 1 125 Trenton-H arbourton Rd. Titusville NJ (18560 Mobi_ 'Dcs_ [90(5) ianssenj? Confidentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e?mail address. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson 8: Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you. b,?F?dease consider the environment before printing this email From: Scher, Deborah L. Sent: Monday, July 29, 2019 12:24 PM To: Cc: Wilson, Breanne L. Subject: RE: RE: Following up - Virtual Clinical Trials Hi Phil: Thank you for your note. We are very much looking forward to this call. I like your plan. After your intros, i would like to turn the call over to Dr-to elaborate on his vision for what we might do together. We appreciate your organizing your team on short notice. Best, Deborah From: [5013} Sent: Monday, July 29, 2019 9:19 AM To: Scher, Deborah L. {Deborah.5cher@va.gov> Cc: Wilson, Breanna L. Subject: RE: Following up - Virtual Clinical Trials (19-09764-F) - 000064 Hi Deborah, A quick note to follow up on our call today 4p. We?ll have 4 folks from our medical affairs and R810 teams joining us. As you might imagine, we?re working in ironing out the process on our end as well. After you welcome and introduce the group, please kick it over to me and VII try to keep the intros efficient. Glad we were able to make the connection today All the best, Phil PharmD, MS Scienti?c Director. National Accounts Real World Value Evidence. Field Scienti?c Affairs LLC 1 125 Trenton-H arbourton Rd. Titusville. NJ 08560 Mobile:? Dcskihli?l ianssenj? Confidentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this e?mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you. ?Please consider the environment before printing this email From: Scher, Deborah L. Subject: RE: RE: Following up - Virtual Clinical Trials Good morning- I hope you had a nice weekend and managed to stay cool. I had a brief conversation with Dr._on Friday. He is eager to move forward on this. A helpful next step would be to arrange a call with a small group of people to share thoughts on how we might best to do a first virtual trial together in lung cancer and then arrange a follow up working session. Bre can coordinate the VA participants which would include Drs_ and me. Who should she work with on your team? Would be great to get this scheduled for this week or the early part of next week. (19-09764-F) - 000065 Thank you verv much for your partnership on this, Best, Deborah Deborah Lafer Scher Executive Advisor to the Secretary Secretarv?s Center for Strategic Partnerships U.S. Department of Veterans Affairs SCSQ From: {bire[coslu51_@ Date: Wednesday, Jul 2019, 9:19 AM To: Scher, Deborah L. Subject: RE: Following up - Virtual Clinical Trials Hi Deborah, Correct and I met vesterdav to move the process forward. Mv ask about some additional information regarding virtual clinical trials was to inquire as to whether there was something approved to circulate for this ask. Dk if there?s nothing available, just thought to ask. We arrived on a list of stakeholders that we?d include and will look to you for dates in August once Dr. -gets back up and running after vacation! Thanks, a Pharml), MS Scienti?c Director, National Accounts Real World Value 3: Evidence. Field Janssen Scienti?c Affairs LLC [125 Ti'onlon-Iiarbounon Rd. Titusville, NJ 08560 Janssenj' Confidentiality Notice: This email transmission mav contain con?dential or legallv privileged information that is intended only for the individual or entity named in the evmail address. If you are not the intended recipient, you are hereby noti?ed that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictlv prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson EL Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you. ?Please consider the environment before printing this email From: Scher, Deborah L. Subject: Following up - Virtual Clinical Trials Hi Deborah, Great speaking with you last week! I wanted to follow with a few things: 1. I believe we landed on lung cancer as our first order of business. Was that your expectation? i know prostate cancer is also a focus for youfyour population, but i also know we have more pipeline innovations to consider in lung. 2. If that works, could you provide some dates times (say 5) in the mid to late August time frame that would work for a meeting between our teams? 3. Could you share a one-pager with me that I could use to accurately socialize the concept with my internal stakeholders? Let me know what you think and we?ll work through next steps Thanks, (19-09764-F) - 000067 ?PharmD~ MS Scienti?c Director, National Accounts Real World Value Evidence, Field Janssen Scienti?c Affairs LLC 1 125 Trenton-Harbourton Rd. Titusvi le NJ 08560 Mobil {hm Desk Fi?! Iona} hiitsinixom ianssenj? Confidentiality Notice: This e?mail transmission may contain con?dential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you. consider the environment before printing this email (19-09764-F) - 000068 From: ltbk?i 1m lotto] [scousi Sent: 25 Jul 2019 14:14:41 +0000 To: Scher, Deborah L. Subject: Follow up from our conversation Attachments: Deborah Great touching base with you today. Here are some follow ups: 1. Attachment of the AHA Roundtable work that has been done for Mental Health in the Employer space. 2. _-title is VP of Global Health Services/ Health and Wellness World Wide, let me know if you would like to speak to her about your Employer Challenge Initiative. 3. Finally the main VA person who is opposite who could help you further understand the previous m. role is lElE?ll?l Is it Friday yet?? (5-31 nuan- Him? cw; sever-19 Im: bM {ch . . _?itsfn'com . .. -- . .. .- .. . +2.1 .H I Confidentiality Notice: This e?mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e?mail address. If you are not the intended recipient. you are hereby noti?ed that any disclosure. copying. distribution, or reliance upon the contents of this e?mail is strictly prohibited. If you have received this email transmission in error. please reply to the sender. so that Johnson 8. Johnson can arrange for proper delivery. and then please delete the message from your inbox. Thank you. (19-09764-F) - 000069 (19-09764-F) - 000070 (19-09764-F) - 000071 (19-09764-F) - 000072 (19-09764-F) - 000073 (19-09764-F) - 000074 (19-09764-F) - 000075 (19-09764-F) - 000076 (19-09764-F) - 000077 (19-09764-F) - 000078 (19-09764-F) - 000079 (19-09764-F) - 000080 (19-09764-F) - 000081 (19-09764-F) - 000082 (19-09764-F) - 000083 (19-09764-F) - 000084 (19-09764-F) - 000085 (19-09764-F) - 000086 (19-09764-F) - 000087 (19-09764-F) - 000088 (19-09764-F) - 000089 (19-09764-F) - 000090 (19-09764-F) - 000091 (19-09764-F) - 000092 (19-09764-F) - 000093 (19-09764-F) - 000094 (19-09764-F) - 000095 (19-09764-F) - 000096 (19-09764-F) - 000097 (19-09764-F) - 000098 (19-09764-F) - 000099 (19-09764-F) - 000100 (19-09764-F) - 000101 (19-09764-F) - 000102 (19-09764-F) - 000103 (19-09764-F) - 000104 (19-09764-F) - 000105 (19-09764-F) - 000106 (19-09764-F) - 000107 (19-09764-F) - 000108 (19-09764-F) - 000109 (19-09764-F) - 000110 (19-09764-F) - 000111 (19-09764-F) - 000112 (19-09764-F) - 000113 (19-09764-F) - 000114 (19-09764-F) - 000115 (19-09764-F) - 000116 (19-09764-F) - 000117 (19-09764-F) - 000118 (19-09764-F) - 000119 (19-09764-F) - 000120 (19-09764-F) - 000121 (19-09764-F) - 000122 (19-09764-F) - 000123 (19-09764-F) - 000124 (19-09764-F) - 000125 (19-09764-F) - 000126 (19-09764-F) - 000127 (19-09764-F) - 000128 (19-09764-F) - 000129 (19-09764-F) - 000130 (19-09764-F) - 000131 (19-09764-F) - 000132 (19-09764-F) - 000133 (19-09764-F) - 000134 (19-09764-F) - 000135 (19-09764-F) - 000136 (19-09764-F) - 000137 (19-09764-F) - 000138 (19-09764-F) - 000139 (19-09764-F) - 000140 (19-09764-F) - 000141 (19-09764-F) - 000142 (19-09764-F) - 000143 (19-09764-F) - 000144 (19-09764-F) - 000145 (19-09764-F) - 000146 (19-09764-F) - 000147 (19-09764-F) - 000148 (19-09764-F) - 000149 (19-09764-F) - 000150 (19-09764-F) - 000151 (19-09764-F) - 000152 (19-09764-F) - 000153 (19-09764-F) - 000154 (19-09764-F) - 000155 (19-09764-F) - 000156 (19-09764-F) - 000157 (19-09764-F) - 000158 (19-09764-F) - 000159 (19-09764-F) - 000160 (19-09764-F) - 000161 (19-09764-F) - 000162 (19-09764-F) - 000163 (19-09764-F) - 000164 (19-09764-F) - 000165 (19-09764-F) - 000166 (19-09764-F) - 000167 (19-09764-F) - 000168 (19-09764-F) - 000169 (19-09764-F) - 000170 (19-09764-F) - 000171 (19-09764-F) - 000172 (19-09764-F) - 000173 (19-09764-F) - 000174 (19-09764-F) - 000175 (19-09764-F) - 000176 (19-09764-F) - 000177 (19-09764-F) - 000178 (19-09764-F) - 000179 (19-09764-F) - 000180 (19-09764-F) - 000181 (19-09764-F) - 000182 (19-09764-F) - 000183 (19-09764-F) - 000184 (19-09764-F) - 000185 (19-09764-F) - 000186 (19-09764-F) - 000187 (19-09764-F) - 000188 (19-09764-F) - 000189 (19-09764-F) - 000190 (19-09764-F) - 000191 (19-09764-F) - 000192 (19-09764-F) - 000193 (19-09764-F) - 000194 (19-09764-F) - 000195 (19-09764-F) - 000196 (19-09764-F) - 000197 (19-09764-F) - 000198 (19-09764-F) - 000199 (19-09764-F) - 000200 (19-09764-F) - 000201 (19-09764-F) - 000202 (19-09764-F) - 000203 (19-09764-F) - 000204 (19-09764-F) - 000205 (19-09764-F) - 000206 (19-09764-F) - 000207 (19-09764-F) - 000208 (19-09764-F) - 000209 (19-09764-F) - 000210 (19-09764-F) - 000211 (19-09764-F) - 000212 (19-09764-F) - 000213 (19-09764-F) - 000214 (19-09764-F) - 000215 (19-09764-F) - 000216 (19-09764-F) - 000217 (19-09764-F) - 000218 (19-09764-F) - 000219 (19-09764-F) - 000220 (19-09764-F) - 000221 (19-09764-F) - 000222 (19-09764-F) - 000223 (19-09764-F) - 000224 (19-09764-F) - 000225 (19-09764-F) - 000226 (19-09764-F) - 000227 (19-09764-F) - 000228 (19-09764-F) - 000229 (19-09764-F) - 000230 (19-09764-F) - 000231 (19-09764-F) - 000232 (19-09764-F) - 000233 (19-09764-F) - 000234 (19-09764-F) - 000235 (19-09764-F) - 000236 (19-09764-F) - 000237 (19-09764-F) - 000238 (19-09764-F) - 000239 (19-09764-F) - 000240 (19-09764-F) - 000241 (19-09764-F) - 000242 (19-09764-F) - 000243 (19-09764-F) - 000244 (19-09764-F) - 000245 (19-09764-F) - 000246 (19-09764-F) - 000247 (19-09764-F) - 000248 (19-09764-F) - 000249 (19-09764-F) - 000250 (19-09764-F) - 000251 (19-09764-F) - 000252 (19-09764-F) - 000253 (19-09764-F) - 000254 (19-09764-F) - 000255 (19-09764-F) - 000256 (19-09764-F) - 000257 (19-09764-F) - 000258 (19-09764-F) - 000259 (19-09764-F) - 000260 (19-09764-F) - 000261 (19-09764-F) - 000262 (19-09764-F) - 000263 (19-09764-F) - 000264 (19-09764-F) - 000265 (19-09764-F) - 000266 (19-09764-F) - 000267 (19-09764-F) - 000268 (19-09764-F) - 000269 (19-09764-F) - 000270 (19-09764-F) - 000271 (19-09764-F) - 000272 (19-09764-F) - 000273 (19-09764-F) - 000274 (19-09764-F) - 000275 (19-09764-F) - 000276 (19-09764-F) - 000277 (19-09764-F) - 000278 (19-09764-F) - 000279 (19-09764-F) - 000280 (19-09764-F) - 000281 (19-09764-F) - 000282 (19-09764-F) - 000283 (19-09764-F) - 000284 (19-09764-F) - 000285 (19-09764-F) - 000286 (19-09764-F) - 000287 (19-09764-F) - 000288 (19-09764-F) - 000289 (19-09764-F) - 000290 (19-09764-F) - 000291 (19-09764-F) - 000292 (19-09764-F) - 000293 (19-09764-F) - 000294 (19-09764-F) - 000295 (19-09764-F) - 000296 (19-09764-F) - 000297 (19-09764-F) - 000298 (19-09764-F) - 000299 (19-09764-F) - 000300 (19-09764-F) - 000301 (19-09764-F) - 000302 (19-09764-F) - 000303 (19-09764-F) - 000304 (19-09764-F) - 000305 (19-09764-F) - 000306 (19-09764-F) - 000307 (19-09764-F) - 000308 (19-09764-F) - 000309 (19-09764-F) - 000310 (19-09764-F) - 000311 (19-09764-F) - 000312 (19-09764-F) - 000313 (19-09764-F) - 000314 (19-09764-F) - 000315 (19-09764-F) - 000316 (19-09764-F) - 000317 (19-09764-F) - 000318 (19-09764-F) - 000319 (19-09764-F) - 000320 (19-09764-F) - 000321 (19-09764-F) - 000322 (19-09764-F) - 000323 (19-09764-F) - 000324 (19-09764-F) - 000325 (19-09764-F) - 000326 (19-09764-F) - 000327 (19-09764-F) - 000328 (19-09764-F) - 000329 (19-09764-F) - 000330 (19-09764-F) - 000331 (19-09764-F) - 000332 (19-09764-F) - 000333 (19-09764-F) - 000334 (19-09764-F) - 000335 (19-09764-F) - 000336 (19-09764-F) - 000337 (19-09764-F) - 000338